Korea Investment CORP Has $6.86 Million Stock Position in Molina Healthcare, Inc $MOH

Key Points

• Korea Investment CORP reduced its stake in Molina Healthcare by 32.0%, now holding 20,830 shares worth approximately $6.86 million.
• Various institutional investors are actively trading Molina Healthcare's stock, with GAMMA Investing LLC increasing its stake by over 74,593.7% to total 667,015 shares valued at around $219.7 million.
• Wall Street analysts have downgraded Molina Healthcare's shares, with Morgan Stanley lowering its target price from $364 to $266 and changing its rating to "equal weight."

Korea Investment CORP reduced its position in Molina Healthcare, Inc (NYSE:MOH - Free Report) by 32.0% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 20,830 shares of the company's stock after selling 9,800 shares during the period. Korea Investment CORP's holdings in Molina Healthcare were worth $6,861,000 as of its most recent filing with the SEC.

Several other hedge funds have also bought and sold shares of MOH. GAMMA Investing LLC lifted its stake in Molina Healthcare by 74,593.7% in the 1st quarter. GAMMA Investing LLC now owns 667,015 shares of the company's stock valued at $219,708,000 after purchasing an additional 666,122 shares during the last quarter. Voloridge Investment Management LLC lifted its stake in Molina Healthcare by 1,641.3% in the 4th quarter. Voloridge Investment Management LLC now owns 409,807 shares of the company's stock valued at $119,274,000 after purchasing an additional 386,273 shares during the last quarter. Two Sigma Investments LP acquired a new stake in Molina Healthcare in the 4th quarter valued at about $44,099,000. Nuveen LLC acquired a new stake in Molina Healthcare in the 1st quarter valued at about $46,441,000. Finally, BNP Paribas Financial Markets lifted its stake in Molina Healthcare by 138.4% in the 4th quarter. BNP Paribas Financial Markets now owns 177,150 shares of the company's stock valued at $51,560,000 after purchasing an additional 102,840 shares during the last quarter. 98.50% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, COO James Woys purchased 10,000 shares of Molina Healthcare stock in a transaction that occurred on Monday, August 4th. The shares were acquired at an average price of $155.94 per share, with a total value of $1,559,400.00. Following the completion of the transaction, the chief operating officer directly owned 74,331 shares of the company's stock, valued at $11,591,176.14. This represents a 15.54% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Ronna Romney sold 700 shares of the business's stock in a transaction that occurred on Wednesday, August 6th. The shares were sold at an average price of $153.74, for a total transaction of $107,618.00. Following the transaction, the director owned 17,131 shares of the company's stock, valued at approximately $2,633,719.94. This represents a 3.93% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.10% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on MOH. Morgan Stanley downgraded shares of Molina Healthcare from an "overweight" rating to an "equal weight" rating and cut their target price for the company from $364.00 to $266.00 in a research note on Thursday, July 10th. JPMorgan Chase & Co. lowered their price target on shares of Molina Healthcare from $272.00 to $184.00 and set a "neutral" rating on the stock in a report on Tuesday, July 29th. Wall Street Zen cut shares of Molina Healthcare from a "buy" rating to a "hold" rating in a report on Sunday, June 29th. Robert W. Baird lowered their price target on shares of Molina Healthcare from $373.00 to $179.00 and set a "neutral" rating on the stock in a report on Friday, July 25th. Finally, UBS Group lowered their price target on shares of Molina Healthcare from $260.00 to $180.00 and set a "neutral" rating on the stock in a report on Friday, July 25th. Three investment analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $242.91.

Molina Healthcare Trading Up 0.9%

Shares of MOH stock opened at $174.30 on Friday. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.77. The stock has a market cap of $9.45 billion, a P/E ratio of 8.59 and a beta of 0.52. The stock has a 50 day simple moving average of $211.01 and a 200 day simple moving average of $277.08. Molina Healthcare, Inc has a 1 year low of $151.95 and a 1 year high of $365.23.

Molina Healthcare (NYSE:MOH - Get Free Report) last issued its quarterly earnings results on Wednesday, July 23rd. The company reported $5.48 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $5.50 by ($0.02). The company had revenue of $11.43 billion for the quarter, compared to analyst estimates of $10.94 billion. Molina Healthcare had a return on equity of 27.72% and a net margin of 2.60%.The company's quarterly revenue was up 15.7% compared to the same quarter last year. During the same period in the prior year, the company earned $5.86 EPS. On average, research analysts predict that Molina Healthcare, Inc will post 24.4 earnings per share for the current fiscal year.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.